Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Elekta AB's interest expense for the
three
months ended in Apr. 2026 was $ -13 Mil.
Its interest expense for the trailing twelve months (TTM) ended in Apr. 2026 was $-40 Mil.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Elekta AB's Operating Income for the
three
months ended in Apr. 2026 was $ -57 Mil. Elekta AB's Interest Expense for the
three
months ended in Apr. 2026 was $ -13 Mil.
Elekta AB did not have earnings to cover the interest expense.
The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Elekta AB (OTCPK:EKTAF) Interest Expense Explanation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.
Elekta AB's Interest Coverage for the quarter that ended in Apr. 2026 is calculated as
Elekta AB did not have earnings to cover the interest expense.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The higher the ratio, the stronger the company's financial strength is.
Elekta AB Interest Expense Historical Data
* Premium members only.
The historical data trend for Elekta AB's Interest Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Interest Expense is the amount reported by a company or individual as an expense for borrowed money.
Interest Expense for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-40 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Elekta AB (EKTAF) has a Interest Expense of $-40 Mil as of Apr. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Elekta AB and its competitors.
Is Elekta AB's Interest Expense too high?
Elekta AB's current Interest Expense is $-40 Mil. Overall, Elekta AB has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Elekta AB's Interest Expense compare to ABT and SYK?
Elekta AB's Interest Expense of $-40 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Medical Devices & Instruments company?
A good Interest Expense depends on the Medical Devices & Instruments industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Elekta AB and its competitors. Elekta AB's current Interest Expense is $-40 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elekta AB stock overvalued right now?
Based on GuruFocus' analysis, Elekta AB (EKTAF) is currently considered Modestly Undervalued. The stock's GF Value™ is $6.92, compared to a current price of $5.25 — trading 24.1% below its estimated fair value. The current Interest Expense is $-40 Mil. Elekta AB's overall GF Score™ is 79/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Elekta AB (EKTAF), the current Interest Expense is $-40 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Elekta AB (EKTAF) Overvalued in 2026?
Based on GuruFocus' analysis, Elekta AB stock appears to be undervalued.
The current stock price of $5.25 is trading 24.1% below its estimated GF Value™ of $6.92.
GuruFocus considers Elekta AB to be Modestly Undervalued.
Key valuation signals for EKTAF:
Interest Expense: $-40 Mil
GF Value™: $6.92 vs. price of $5.25 (24.1% below fair value)
No single metric tells the full story. See the EKTAF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company has an installed base of more than 7,300 linear accelerators, Gamma Knife and Unity platforms, as well as brachytherapy installations. The company's sales are evenly distributed across geographies, with North and South America accounting for 29%; Europe, the Middle East, and Africa accounting for 37%; and the Asia-Pacific contributing the remainder.
79GF Score
Get the complete analysis for EKTAF
Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EKTAF has been successfully added to your 
